iX Biopharma42C 
$0.020.00%24h
0.00%24h
Global rank29407
Market cap$12.99M
Change 7d0.00%
YTD Performance-48.89%
SP500 benchmarkUnderperform
P/E0
P/S2.98
Revenue$4.36M
Earnings-$7.08M
Dividend yield-
Main Sector
Healthcare
Category
iX Biopharma 42C Total Debt
42C Total Debt in 2022: $844.35K
According to iX Biopharma latest financial reports the total debt is $844.35K, an increase of 30.82% to 2022. At the end of 2022 company had $645.42K total debt. This figure represents the debts and financial obligations that iX Biopharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
iX Biopharma 42C Total Debt History from 2023 to 2022
-
Value:-
42C Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $844.35K | 30.82% |
| 2022 | $645.42K | -74.53% |
| 2021 | $2.53M | -0.52% |
| 2020 | $2.55M | -4.50% |
| 2019 | $2.67M | - |
View the Top Total Debt Stocks 
